The dark side of the ‘miracle jab’: why eating disorder safety cannot be an afterthought As the use of glucagon-like peptide-1 receptor agonists increases, so must our awareness of patients who have an eating disorder or who are at risk of developing one.…
Health news round-up: travel warnings, AMR in children, and the latest on medicine supply A weekly summary of important developments in pharmacy and health news that you may have missed.…
Everything you need to know about GLP-1s for weight loss From semaglutide to tirzepatide, this article collates the latest information on pharmacological weight-loss treatments, including evidence and best practice for their use.…
Managing neuropathic pain in bipolar disorder An overview of the clinical considerations for managing comorbid bipolar disorder and neuropathic pain.…
Almost half of weight-loss drug users modify doses, finds survey Results from a survey conducted by LloydsPharmacy Online Doctor also showed that more than one-quarter of respondents said they had knowingly bought weight-loss injections from unlicensed sellers.…
Weight-loss drugs among £45m of illegally traded medicines seized in 2025 Medicines and Healthcare products Regulatory Agency figures show that more than 5,000 glucagon-like peptide-1 products were seized in 2025.…
Drug consumption room pilot records more than 1,000 injecting episodes in a month According to latest service data on The Thistle, a drug consumption facility in Glasgow, 560 people used the site's services more than 10,000 times in 2025.…
Health news round-up: prescribing, deprescribing and medication considerations A weekly summary of important developments in health news that you may have missed.…
Guild of Healthcare Pharmacists recommends ‘ring-fencing’ diamorphine stock amid supply issues Medicine supply alerts sent in December 2025 and January 2026 have requested that prescribers switch to morphine sulphate 10mg/1mL injections, where possible.…
Higher-dose Wegovy could increase patient expectation, warns PDA The Medicines and Healthcare products Regulatory Agency has approved a 7.2mg dose of Wegovy after the higher dose showed success in clinical trial patients.…
